Close
ACHEMA MIDDLE EAST 2026

Europe API Market To Reach $80bn By 2033 – Study Predicts

The active pharma ingredient market in Europe has been a matter of much discussion, and no wonder it has laid a very exclusive but...

$1.5bn Manufacturing Plant By AstraZeneca In Singapore Soon

On May 20, 2024, AstraZeneca, the global biopharma company, announced plans to build a $1.5 billion manufacturing facility in Singapore. With this announcement, the...

Growing Market Size – US Clinical Trials Supply & Logistics

As per a study conducted in May 2024, the US clinical trials supply and logistics market size was placed at $1.90 billion in 2023...

Ideas To Improve Availability of Critical Drugs Made By EMA

As the EU health ministers go on to gather in Brussels on April 23–24 in order to discuss access when it comes to critical...

Clinical Research Ecosystem Making Utmost Gene Therapy Use?

It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first...

Fresh Biologics Clinical Manufacturing CDMO Service Trends

In the ever-changing pharma and biologics sector, the Biologics Clinical Manufacturing CDMO Service market has gone on to emerge as quite a prominent player...

CDMOs Using Specialized Solutions To Meet Cold Chain Needs

It is worth noting that the Cell and gene therapies- CGTs have gone on to show immense promise when it comes to treating diverse...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...